Since its inception, IMAGEENS has demonstrated its ability to leverage advanced AI to build cutting-edge medical software. This innovation has been recognized through several prestigious French innovation competitions (ILAB, PIA, PIA Leader, INSERM Innovation Prize) and multiple innovation labels (Jeune Entreprise Innovante (JEI) and Startup DeepTech).

Today, IMAGEENS is a spearhead company in the rapidly growing field of AI in cardiovascular health. IMAGEENS has the world’s most clinically validated technology to analyse arterial function by MRI, and is deploying this technology in combination with other AI components to revolutionize treatment decisions in cardiovascular health.